This pipeline uses various statistical tests to identify RPPAs whose expression levels correlated to selected clinical features.
Testing the association between 175 genes and 5 clinical features across 155 samples, statistically thresholded by Q value < 0.05, 4 clinical features related to at least one genes.
-
18 genes correlated to 'AGE'.
-
SNAI2|SNAIL-M-C , AKT1 AKT2 AKT3|AKT_PS473-R-V , EEF2|EEF2-R-V , EGFR|EGFR_PY1068-R-V , PIK3R1|PI3K-P85-R-V , ...
-
46 genes correlated to 'HISTOLOGICAL.TYPE'.
-
ANXA1|ANNEXIN_I-R-V , FN1|FIBRONECTIN-R-C , CHEK2|CHK2-M-C , IRS1|IRS1-R-V , C12ORF5|TIGAR-R-V , ...
-
8 genes correlated to 'RADIATIONS.RADIATION.REGIMENINDICATION'.
-
ERBB2|HER2_PY1248-R-V , ARID1A|ARID1A-M-V , WWTR1|TAZ_PS89-R-C , CDKN1B|P27_PT157-R-C , MET|C-MET-M-C , ...
-
2 genes correlated to 'NEOADJUVANT.THERAPY'.
-
NF2|NF2-R-C , EIF4E|EIF4E-R-V
-
No genes correlated to 'GENDER'
Complete statistical result table is provided in Supplement Table 1
Clinical feature | Statistical test | Significant genes | Associated with | Associated with | ||
---|---|---|---|---|---|---|
AGE | Spearman correlation test | N=18 | older | N=8 | younger | N=10 |
GENDER | t test | N=0 | ||||
HISTOLOGICAL TYPE | ANOVA test | N=46 | ||||
RADIATIONS RADIATION REGIMENINDICATION | t test | N=8 | yes | N=6 | no | N=2 |
NEOADJUVANT THERAPY | t test | N=2 | yes | N=0 | no | N=2 |
AGE | Mean (SD) | 46.58 (16) |
Significant markers | N = 18 | |
pos. correlated | 8 | |
neg. correlated | 10 |
SpearmanCorr | corrP | Q | |
---|---|---|---|
SNAI2|SNAIL-M-C | 0.3726 | 1.801e-06 | 0.000315 |
AKT1 AKT2 AKT3|AKT_PS473-R-V | 0.3708 | 2.044e-06 | 0.000356 |
EEF2|EEF2-R-V | -0.3662 | 2.777e-06 | 0.00048 |
EGFR|EGFR_PY1068-R-V | 0.3483 | 8.944e-06 | 0.00154 |
PIK3R1|PI3K-P85-R-V | -0.3411 | 1.403e-05 | 0.0024 |
ATM|ATM-R-C | -0.3361 | 1.91e-05 | 0.00325 |
MAPK8|JNK_PT183_PT185-R-V | 0.3346 | 2.089e-05 | 0.00353 |
YAP1|YAP_PS127-R-C | -0.3291 | 2.894e-05 | 0.00486 |
AKT1 AKT2 AKT3|AKT_PT308-R-V | 0.3283 | 3.034e-05 | 0.00507 |
BID|BID-R-C | -0.3283 | 3.043e-05 | 0.00507 |
GENDER | Labels | N |
FEMALE | 106 | |
MALE | 49 | |
Significant markers | N = 0 |
HISTOLOGICAL.TYPE | Labels | N |
OTHER | 7 | |
THYROID PAPILLARY CARCINOMA - CLASSICAL/USUAL | 83 | |
THYROID PAPILLARY CARCINOMA - FOLLICULAR (>= 99% FOLLICULAR PATTERNED) | 52 | |
THYROID PAPILLARY CARCINOMA - TALL CELL (>= 50% TALL CELL FEATURES) | 13 | |
Significant markers | N = 46 |
ANOVA_P | Q | |
---|---|---|
ANXA1|ANNEXIN_I-R-V | 7.948e-19 | 1.39e-16 |
FN1|FIBRONECTIN-R-C | 4.058e-13 | 7.06e-11 |
CHEK2|CHK2-M-C | 9.245e-11 | 1.6e-08 |
IRS1|IRS1-R-V | 1.125e-10 | 1.94e-08 |
C12ORF5|TIGAR-R-V | 1.268e-10 | 2.17e-08 |
PIK3R1|PI3K-P85-R-V | 5.673e-10 | 9.64e-08 |
RAF1|C-RAF_PS338-R-C | 1.018e-09 | 1.72e-07 |
CDKN1B|P27_PT157-R-C | 1.112e-09 | 1.87e-07 |
STK11|LKB1-M-C | 8.732e-09 | 1.46e-06 |
MET|C-MET-M-C | 8.905e-09 | 1.48e-06 |
8 genes related to 'RADIATIONS.RADIATION.REGIMENINDICATION'.
RADIATIONS.RADIATION.REGIMENINDICATION | Labels | N |
NO | 13 | |
YES | 142 | |
Significant markers | N = 8 | |
Higher in YES | 6 | |
Higher in NO | 2 |
T(pos if higher in 'YES') | ttestP | Q | AUC | |
---|---|---|---|---|
ERBB2|HER2_PY1248-R-V | 4.72 | 4.656e-05 | 0.00815 | 0.7161 |
ARID1A|ARID1A-M-V | 4.48 | 0.0001079 | 0.0188 | 0.7048 |
WWTR1|TAZ_PS89-R-C | 4.93 | 0.0001088 | 0.0188 | 0.8028 |
CDKN1B|P27_PT157-R-C | 4.66 | 0.000151 | 0.026 | 0.7557 |
MET|C-MET-M-C | 4.35 | 0.0001511 | 0.026 | 0.6853 |
IRS1|IRS1-R-V | 4.5 | 0.0001591 | 0.027 | 0.7183 |
DVL3|DVL3-R-V | -4.63 | 0.0001852 | 0.0313 | 0.7841 |
BCL2L1|BCL-XL-R-V | -4.78 | 0.0002339 | 0.0393 | 0.825 |
NEOADJUVANT.THERAPY | Labels | N |
NO | 3 | |
YES | 152 | |
Significant markers | N = 2 | |
Higher in YES | 0 | |
Higher in NO | 2 |
T(pos if higher in 'YES') | ttestP | Q | AUC | |
---|---|---|---|---|
NF2|NF2-R-C | -7.23 | 1.596e-05 | 0.00279 | 0.7939 |
EIF4E|EIF4E-R-V | -9.72 | 2.247e-05 | 0.00391 | 0.8816 |
-
Expresson data file = THCA.rppa.txt
-
Clinical data file = THCA.clin.merged.picked.txt
-
Number of patients = 155
-
Number of genes = 175
-
Number of clinical features = 5
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.